Membership Qualifications
Membership in ISIA is available to companies actively engaged in, or associated with, the collection, sale, distribution, and processing of serum, as defined in Article 2, Section 2.1 of the ISIA bylaws.

Regular Membership
Regular Membership is available to companies and groups actively engaged in the collection, sale, distribution, and processing of serum as defined in Article 2, Section 2.1. Regular Members have voting rights (one (1) vote per Member Company). Paid membership allows for up to two (2) participant Members at identified ISIA meetings and functions, a primary and alternate. While each member holding regular membership will be eligible to serve as directors and officers, only the designated primary member will be allowed to vote.

Additionally, employees of member companies can attend ISIA meetings as invited. These members do NOT have voting rights nor can they serve as directors or officers. Planned participation in meetings will be indicated in writing in advance. A nominal meeting fee will be charged to cover associated costs.

Affiliate membership
Affiliate membership is available to companies in the serum business who are part of or partnered with another member company. Affiliate Members do not have voting rights, and they and their employees are not eligible to serve as directors or officers . Planned participation in meetings must be indicated in writing in advance. A nominal meeting fee will be charged to cover associated costs.

Associate Membership
Associate Membership is available to individuals, companies, universities, research institutions, government agencies and other organizations engaged in ancillary activities and in supportive functions and not actively engaged in the collection, sale, distribution, and processing of serum as defined in Article 2, Section 2.1. Associate Members are limited to attendance at ISIA meetings as invited, and to ISIA publications. Associate Members do not have voting rights, and they and their employees are not eligible to serve as directors or officers.

Dues Structure

Last year in Dresden, the Association approved a wholly apportioned approach to dues assessment in which each regular member pays a set percentage of their self-reported revenues from serum. This new structure requires that companies report revenues for the preceding fiscal year as defined by the following statements:

• This figure is to be derived only from end-user revenues for each member group
  or company. Internal transfers should not be included.
• Each member should draw this figure from their most recent audited financials
• Each member should include only revenue generated from the sales of animal
  blood products for use in life science research, diagnostic kit production and the
  manufacturing of biopharmaceutical products and vaccines.

The ISIA has contracted with Maloney & Associates PLLC, an independent, third-party bookkeeper to collect this revenue data from all members, calculate proportionate dues, generate and distribute invoices to each member, and collect monies for aggregate transfer into the ISIA accounts. In this way, no-one within the Association will have any knowledge of the numbers submitted.

Current Members

For a full listing see the News section